New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SOPHiA GENETICS SA
SOPH
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

202M

Medical - Healthcare Information Services

Next Earning date - 06 May 2025

202M

Medical - Healthcare Information Services

Next Earning date - 06 May 2025

3.67USD

Shape0.07 ( 1.94%)
Market Closed (as of Feb 28, 21:00 EDT)
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-63%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

42%

Quote Panel

Shape
Updated March 24, 2025
1W -5.92 % 1M -19.25 % 3M -5.33 % 1Y -36.82 %

Key Metrics

Shape
  • Market Cap

    201.83M


  • Shares Outstanding

    66.83M


  • Share in Float

    52.29M


  • Dividende

    0


  • Earning Date

    06 May 2025


  • Price Target

    3.02


  • Average Volume

    80974


  • Beta

    1.013


  • Range

    2.7-6.28


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.sophiagenetics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.10x

P/S Ratio

2.07x

P/B Ratio

0.3

Debt/Equity

-95.9%

Net Margin

$-0.9

EPS

How SOPH compares to sector?

P/E Ratio

Relative Strength

Shape

SOPH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$73M

Shape314%

2025-Revenue

$0.80

Shape-247%

2025-EPS

$70M

Shape-784%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

5.00(65.56%)

Number of analyst

1

Last analyst upgrade/downgrade

Craig-Hallum

initialise

Previous: Not converted

2024-12-18

Now: Buy

Morgan Stanley

downgrade

Previous: Not converted

2024-08-07

Now: Equal-Weight

Morgan Stanley

downgrade

Previous: Not converted

2024-08-07

Now: Positive

Guggenheim

initialise

Previous: Not converted

2024-06-27

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.31
vs -0.40

Q2.23

arrow
arrow

N/A

-0.33
vs -0.39

Q3.23

arrow
arrow

N/A

-0.21
vs -0.36

Q4.23

arrow
arrow

N/A

-0.37
vs -0.22

Q1.24

arrow
arrow

N/A

-0.21
vs -0.31

Q2.24

arrow
arrow

N/A

-0.23
vs -0.33

Q3.24

arrow
arrow

N/A

-0.28
vs -0.21

Q4.24

arrow
arrow

N/A

-0.23
vs -0.37

Q1.25

arrow
arrow

N/A

-0.22
vs -0.21

Q2.25

arrow
arrow

N/A

-0.20
vs -0.23

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+29%

14M  vs 10.9M

Q2.23

arrow
arrow

+29%

15.1M  vs 11.7M

Q3.23

arrow
arrow

+40%

16.3M  vs 11.6M

Q4.23

arrow
arrow

+27%

17M  vs 13.4M

Q1.24

arrow
arrow

+13%

15.8M  vs 14M

Q2.24

arrow
arrow

+5%

15.8M  vs 15.1M

Q3.24

arrow
arrow

-3%

15.9M  vs 16.3M

Q4.24

arrow
arrow

+4%

17.7M  vs 17M

Q1.25

arrow
arrow

+6%

16.8M  vs 15.8M

Q2.25

arrow
arrow

+10%

17.4M  vs 15.8M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-11%

-0.11
vs -0.07

Q2.23

arrow
arrow

-12%

-0.12
vs -0.11

Q3.23

arrow
arrow

-9%

-0.09
vs -0.12

Q4.23

arrow
arrow

-16%

-0.16
vs -0.09

Q1.24

arrow
arrow

-10%

-0.10
vs -0.16

Q2.24

arrow
arrow

-13%

-0.13
vs -0.10

Q3.24

arrow
arrow

-16%

-0.16
vs -0.13

Q4.24

arrow
arrow

-16%

-0.16
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

34

34
vs 32

6%

Q2.23

arrow
arrow

35

35
vs 34

3%

Q3.23

arrow
arrow

34

34
vs 35

-3%

Q4.23

arrow
arrow

37

37
vs 34

9%

Q1.24

arrow
arrow

32

32
vs 37

-14%

Q2.24

arrow
arrow

31

31
vs 32

-3%

Q3.24

arrow
arrow

32

32
vs 31

3%

Q4.24

arrow
arrow

38

38
vs 32

19%

Earnings Growth

Latest News